Superhouse Limited (SUPERHOUSE.NS)
INR 152.27
(-2.83%)
INR 152.27
(-2.83%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 6.43 Billion | 7.37 Billion | 6.22 Billion | 5.19 Billion | 5.79 Billion | 6.67 Billion |
| Cost of Revenue | 4.04 Billion | 4.56 Billion | 4.67 Billion | 3.89 Billion | 4.42 Billion | 5.14 Billion |
| Gross Profit | 2.39 Billion | 2.8 Billion | 1.55 Billion | 1.29 Billion | 1.37 Billion | 1.53 Billion |
| Operating Expenses | 1.17 Billion | 2.39 Billion | 1.2 Billion | 937.26 Million | 1.13 Billion | 1.1 Billion |
| Selling, General and Administrative Expenses | 1.17 Billion | 517.31 Million | 481.35 Million | 321.07 Million | 423.13 Million | 433.65 Million |
| Research and Development Expenses | 13.33 Million | 12.79 Million | 10.8 Million | 6.9 Million | 7.53 Million | 4.59 Million |
| Other Expenses | 119.71 Million | 105.75 Million | 55.47 Million | 52.73 Million | 73.41 Million | 45.25 Million |
| Cost and Expenses | 6.39 Billion | 6.96 Billion | 5.87 Billion | 4.83 Billion | 5.55 Billion | 6.24 Billion |
| Operating Income | 227.32 Million | 427.25 Million | 452.62 Million | 391.04 Million | 390.92 Million | 443.26 Million |
| Interest Expense | 154.74 Million | 141.97 Million | 63.07 Million | 83.75 Million | 138.86 Million | 149.27 Million |
| Income Tax Expense | 35.86 Million | 92.05 Million | 110.29 Million | 57.39 Million | 5.32 Million | 107.97 Million |
| Earnings before Tax | 153.12 Million | 371.28 Million | 424.6 Million | 301.34 Million | 267.76 Million | 317 Million |
| Net Income | 138.29 Million | 302.51 Million | 355.5 Million | 279.79 Million | 262.44 Million | 209.02 Million |
| Earnings Per Share Basic | 12.86 | 24.04 | 32.24 | 22.13 | 23.80 | 18.96 |
| Earnings Per Share Diluted | 12.86 | 24.04 | 32.24 | 22.13 | 23.80 | 18.96 |
| Weighted Average Shares Outstanding | 10.74 Million | 11.02 Million | 11.02 Million | 11.02 Million | 11.02 Million | 11.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.74 Million | 11.02 Million | 11.02 Million | 11.02 Million | 11.02 Million | 11.02 Million |
| Gross Margin | 0.37 | 0.38 | 0.25 | 0.25 | 0.24 | 0.23 |
| EBIT Margin | 0.04 | 0.09 | 0.10 | 0.10 | 0.10 | 0.09 |
| Profit Margin | 0.02 | 0.04 | 0.06 | 0.05 | 0.05 | 0.03 |
| EBITDA | 276.45 Million | 669.13 Million | 664.32 Million | 567.12 Million | 584.52 Million | 664.36 Million |
| Earnings Before Tax Margin | 0.04 | 0.06 | 0.07 | 0.08 | 0.07 | 0.07 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 1.42 Billion | 5.2 Billion | 1.33 Billion | 1.44 Billion | 1.85 Billion | 1.59 Billion |
| Cost of Revenue | 1.06 Billion | 3.91 Billion | 1 Billion | 1.03 Billion | 1.21 Billion | 986.82 Million |
| Gross Profit | 364.58 Million | 1.29 Billion | 332.12 Million | 407.58 Million | 639.21 Million | 606.94 Million |
| Operating Expenses | 337.46 Million | 1.17 Billion | 300.09 Million | 387.08 Million | 552.74 Million | 562.03 Million |
| Selling, General and Administrative Expenses | 337.46 Million | - | 300.09 Million | 387.08 Million | 343.01 Million | 356.49 Million |
| Research and Development Expenses | - | - | 13.33 Million | - | - | - |
| Other Expenses | 23.27 Million | 119.71 Million | 38.19 Million | 41.95 Million | 20.57 Million | 19 Million |
| Cost and Expenses | 1.4 Billion | 5.08 Billion | 1.3 Billion | 1.42 Billion | 1.76 Billion | 1.54 Billion |
| Operating Income | 27.12 Million | 122.61 Million | 32.03 Million | 20.5 Million | 107.04 Million | 63.9 Million |
| Interest Expense | 43.58 Million | 154.74 Million | 40.46 Million | 34.85 Million | 41.6 Million | 37.82 Million |
| Income Tax Expense | 17.2 Million | 23.79 Million | 3.88 Million | 9.9 Million | 12.7 Million | 10 Million |
| Earnings before Tax | 68.82 Million | 103.05 Million | 28.33 Million | 27.6 Million | 65.43 Million | 26.08 Million |
| Net Income | 54.08 Million | 79.25 Million | 24.44 Million | 21.5 Million | 59.55 Million | 20.92 Million |
| Earnings Per Share Basic | 5.03 | - | 2.22 | 1.95 | 5.40 | 1.90 |
| Earnings Per Share Diluted | 5.03 | - | 2.22 | 1.95 | 5.40 | 1.90 |
| Weighted Average Shares Outstanding | 10.74 Million | 11.02 Million | 11.02 Million | 11.02 Million | 11.02 Million | 11.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 10.74 Million | 11.02 Million | 11.02 Million | 11.02 Million | 11.02 Million | 11.02 Million |
| Gross Margin | 0.26 | 0.25 | 0.25 | 0.28 | 0.35 | 0.38 |
| EBIT Margin | 0.05 | - | 0.05 | 0.04 | 0.08 | 0.07 |
| Profit Margin | 0.04 | 0.02 | 0.02 | 0.01 | 0.03 | 0.01 |
| EBITDA | 72.49 Million | - | 68.47 Million | 64.69 Million | 151.22 Million | 106.68 Million |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.02 | 0.01 | 0.06 | 0.04 |
MPFRY
300253
3MINDIA
CONCORDBIO
RAMCOSYS
CRISIL